Venetia (Vanna) Zachariou, PhD
Professor
Boston University Chobanian & Avedisian School of Medicine
Dept of Pharmacology & Experimental Therapeutics

PhD, Medical College of Georgia



Venetia Zachariou, PhD is professor of neuroscience and pharmacological sciences at the Icahn School of Medicine at Mount Sinai. She studies signal transduction and epigenetic mechanisms of neurological disorders and their treatment using genetic mouse models, genomic assays and brain biochemistry. Current projects investigate transcriptional and epigenetic mechanisms of chronic pain with emphasis on the identification and validation of novel treatments for the management of peripheral neuropathy and other chronic pain conditions. Another line of research in her laboratory investigates the role of G protein signal transduction complexes in drug addiction, opioid analgesia and physical dependence. By understanding intracellular adaptations to peripheral nerve injury and/or prolonged opioid exposure she aims develop novel therapeutics for chronic pain conditions and pain/addiction comorbidities. Her team has identified several intracellular pathways that control the perception and the maintenance of chronic pain states. They also have developed novel interventions in epigenetic pathways that allow transitioning to non-opioid analgesics while preventing the development of physical dependence.

Zachariou received her BSc in pharmacy from the University of Patras, Greece, and her PhD in pharmacology from the Medical College of Georgia. Following a postdoctoral fellowship in the department of psychiatry at Yale University and a junior faculty position at UT Southwestern Medical Center in Dallas, she established her laboratory at the University of Crete School of Medicine. In 2012, she joined the departments of neuroscience and pharmacological sciences at the Icahn School of Medicine at Mount Sinai in New York as an associate professor (with tenure since 2016), and as full professor (since 2018).

Zachariou is a member of the editorial boards of Biological Psychiatry, Molecular Pain, Science Signaling, Neurobiology of Pain, section editor for European Journal of Neuroscience, and member of the NIH MCNP study section. She is a Fellow in the American College of Neuropsychopharmacology and Chair elect for the ASPET Neuropharmacology Division.




Title


Yr Title Project-Sub Proj Pubs
2023 Animal Models Core 5P01DA047233-05-8100
2022 Cellular mechanisms of antidepressant drug actions in neuropathic pain models 3R01NS086444-08S1
2022 A Female Specific Role of RGSz1 in Modulation of Chronic Pain 5R01NS111351-03
2022 Cellular mechanisms of antidepressant drug actions in neuropathic pain models 3R01NS086444-09S1
2022 Cellular mechanisms of antidepressant drug actions in neuropathic pain models 5R01NS086444-09
2022 Cellular mechanisms of antidepressant drug actions in neuropathic pain models 3R01NS086444-09S2
2022 Animal Models Core 5P01DA047233-04-8100
2021 Cellular mechanisms of antidepressant drug actions in neuropathic pain models 3R01NS086444-07S1 12
2021 A Female Specific Role of RGSz1 in Modulation of Chronic Pain 5R01NS111351-02
2021 Cellular mechanisms of antidepressant drug actions in neuropathic pain models 5R01NS086444-08 12
Showing 10 of 31 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Sakloth F, Sanchez-Reyes OB, Ruiz A, Nicolais A, Serafini RA, Pryce KD, Bertherat F, Torres-Berrío A, Gomes I, Devi LA, Wacker D, Zachariou V. A Regional and Projection-Specific Role of RGSz1 in the Ventrolateral Periaqueductal Grey in the Modulation of Morphine Reward. Mol Pharmacol. 2023 Jan; 103(1):1-8. PMID: 36310031; DOI: 10.1124/molpharm.122.000528;
     
  2. Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi K, Golynker I, Panis M, Zimering J, Horiuchi S, Hoagland DA, Møller R, Ruiz A, Kodra A, Overdevest JB, Canoll PD, Borczuk AC, Chandar V, Bram Y, Schwartz R, Lomvardas S, Zachariou V, tenOever BR. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med. 2022 Sep 28; 14(664):eabq3059. PMID: 35857629; PMCID: PMC9210449; DOI: 10.1126/scitranslmed.abq3059;
     
  3. Serafini RA, Frere JJ, Zimering J, Giosan IM, Pryce KD, Golynker I, Panis M, Ruiz A, tenOever B, Zachariou V. SARS-CoV-2 Airway Infection Results in Time-dependent Sensory Abnormalities in a Hamster Model. bioRxiv. 2022 Aug 19. PMID: 36032984; PMCID: PMC9413707; DOI: 10.1101/2022.08.19.504551;
     
  4. Williams AV, Peña CJ, Ramos-Maciel S, Laman-Maharg A, Ordoñez-Sanchez E, Britton M, Durbin-Johnson B, Settles M, Hao R, Yokoyama S, Xu C, Luo PX, Dwyer T, Bhela S, Black AM, Labonté B, Serafini RA, Ruiz A, Neve RL, Zachariou V, Nestler EJ, Trainor BC. Comparative Transcriptional Analyses in the Nucleus Accumbens Identifies RGS2 as a Key Mediator of Depression-Related Behavior. Biol Psychiatry. 2022 Dec 15; 92(12):942-951. PMID: 36075764; PMCID: PMC9794384; DOI: 10.1016/j.biopsych.2022.06.030;
     
  5. Pryce KD, Kang HJ, Sakloth F, Liu Y, Khan S, Toth K, Kapoor A, Nicolais A, Che T, Qin L, Bertherat F, Kaniskan HÜ, Jin J, Cameron MD, Roth BL, Zachariou V, Filizola M. A promising chemical series of positive allosteric modulators of the µ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects. Neuropharmacology. 2021 09 01; 195:108673. PMID: 34153316; PMCID: PMC8410669; DOI: 10.1016/j.neuropharm.2021.108673;
     
  6. Sakloth F, Polizu C, Bertherat F, Zachariou V. Regulators of G Protein Signaling in Analgesia and Addiction. Mol Pharmacol. 2020 12; 98(6):739-750. PMID: 32474445; PMCID: PMC7662521; DOI: 10.1124/mol.119.119206;
     
  7. Sakloth F, Manouras L, Avrampou K, Mitsi V, Serafini RA, Pryce KD, Cogliani V, Berton O, Jarpe M, Zachariou V. HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice. Psychopharmacology (Berl). 2020 Jul; 237(7):2139-2149. PMID: 32388618; PMCID: PMC7470631; DOI: 10.1007/s00213-020-05525-9;
     
  8. Zhou X, Wahane S, Friedl MS, Kluge M, Friedel CC, Avrampou K, Zachariou V, Guo L, Zhang B, He X, Friedel RH, Zou H. Microglia and macrophages promote corralling, wound compaction and recovery after spinal cord injury via Plexin-B2. Nat Neurosci. 2020 03; 23(3):337-350. PMID: 32112058; PMCID: PMC7412870; DOI: 10.1038/s41593-020-0597-7;
     
  9. Serafini RA, Pryce KD, Zachariou V. The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities. Biol Psychiatry. 2020 01 01; 87(1):64-73. PMID: 31806085; PMCID: PMC6954000; DOI: 10.1016/j.biopsych.2019.10.018;
     
  10. Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou SH. Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research. Biomedicines. 2019 Dec 09; 7(4). PMID: 31835422; PMCID: PMC6966425; DOI: 10.3390/biomedicines7040097;
     
Showing 10 of 79 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 79 publications over 26 distinct years, with a maximum of 7 publications in 2011

YearPublications
19962
19973
19981
19992
20003
20013
20023
20034
20043
20053
20063
20073
20084
20094
20117
20121
20132
20144
20152
20163
20174
20182
20194
20204
20211
20224

Contact for Mentoring:

700 Albany St
Boston MA 02118
Google Map


Zachariou's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_
Same Department